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This study aimed to establish the role of social mobilization in mass drug administration (MDA) uptake during the 
National Programme to Eliminate Lymphatic Filariasis (LF) in Kenya. MDA for LF based on diethylcarbamazine 
(DEC) and albendazole using community-based treatment approach has been conducted for three years (2003, 
2005 and 2008) in Kwale and Malindi districts.  
In each district, one high and one low, compliance locations were selected based on 2008 MDA data. From the four 
locations, nine villages were systematically sampled and a total of 965 randomly selected household heads 
interviewed. Sixteen focus group discussions with adult and youth male and female groups and separate in-depth 
interviews with eighty opinion leaders and eighty LF patients with clinical manifestations, purposively selected 
were conducted. Semi-structured interviews were held separately with fifteen community drug distributors, five 
health personnel and four LF coordinators also purposively selected.  
The results showed that knowledge about MDA for LF was not significantly associated with compliance (P>0.05). 
Seventy three percent in low and 78% in high compliance villages knew about MDA. The most common source of 
MDA information given by 49% of respondents in high and 40% in low compliance villages were the community 
drug distributors (CDDs). The content of MDA information received influenced compliance (P< 0.001), 71% in 
high compared to 61% in low compliance villages received correct information. The frequency of receiving MDA 
information also influenced compliance (P< 0.001), 65.5% in high compared to 50% in low compliance villages 
received the correct information at least once before treatment. Opinion towards the source of MDA information 
was also associated with compliance, 46% in high compared to 43% in low compliance villages considered the 
source as adequate (P< 0.001). 
The study results show that for MDA to be successful, information dissemination should be done by all 
stakeholders with the health personnel taking the lead role so that more adequate and factual content is relayed. 
Community sensitization and mobilization should be done repeatedly for all to get the information in good time to 
comply with treatment.  
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In 1997, WHO passed a resolution urging Member 
States to strengthen activities towards eliminating LF as 
a public health problem and requested the Director-
General to mobilize support for global and national 
elimination activities. The principal strategy of LF 
elimination is annual MDA of single-dose DEC or 
ivermectin in combination with albendazole. In its first 
eight years the global elimination programme has 
delivered 1.9 billion treatments to individuals living in 
48 of the 83 endemic countries [1]. Most national 
elimination programmes in Africa are using the 
community directed treatment (ComDT) whereby 
community volunteers known as community drug 
distributors (CDDs) deliver the drugs to individuals at 
the homes following a study between Ghana and Kenya 
that was done to compare Health System Treatment 
(HST) and ComDT and recommended the latter for LF 
elimination in Africa [2].  
Aggressive community sensitization towards the disease 
and elaborate social mobilization are required for the 
elimination programme to be successful. At least 65% 
of the individuals living in the affected communities 
must be convinced to take the drugs even when they 
have no evidence of infection or signs of the disease. No 
group of persons should remain totally untreated after 4 
to 6 rounds of treatment because a group that misses 
treatment in every round and is infected forms a 
reservoir of mf contributing to transmission of the 
infection [3]. However, the global elimination campaign 
is faced with the challenges of persuading people who 
have no symptoms of the disease to take the drugs [4].  
Kenya joined the GPELF in August 2001. The first 
MDA using DEC and albendazole was successfully 
launched in September 2002 in Kilifi District as the first 
implementation unit. The treatment coverage achieved 
was 81%. In this MDA, activities of community 
mobilization, and behavior change communication 
(BCC) were undertaken with financial and technical 
assistance of the World Health Organization (WHO). 
The BCC materials (posters, leaflets and banners) 
written in Kiswahili, the national language, were used to 
sensitize the communities about LF. These materials 
contained basic information on life cycle, causative 
agent, transmission, pathogenesis and control by 
chemotherapy. The posters and leaflets were given to 
the health personnel to sensitize the communities while 
the banners were posted on major roads. Some of the 
posters were posted on walls at dispensaries, schools 
and trading centers. Both print and electronic media 
were also used for awareness creation.  
Public meetings, barazas were used as the main forum 
for sensitizing and mobilizing the communities and the 
peripheral health staff at the dispensaries. The CDDs 
after being adequately trained were used to sensitize the 
communities about the campaign. School children were 
also sensitized and used as agents to take the message 
back home. 
In October 2003, two additional Districts, Kwale and 
Malindi undertook MDA in addition to Kilifi, which 
was undergoing its second round. In March 2005, 
Kwale and Malindi received the second and Kilifi the 
third round and in December 2008, Kwale and Malindi 
received the third and Kilifi the fourth round. Data 
available from the National Programme for the three 
rounds of MDA, 2003, 2005 and 2008 for Kwale and 
Malindi Districts show a drop in the treatment coverage, 
85% to 71% to 64.3% and 77% to 76% to 62.8% 
respectively. The present study aimed to establish the 
role of social mobilization in MDA uptake in the 
National programme to eliminate lymphatic filariasis 
(LF) in Kenya.   
 
Materials and Methods 
Study area 
This study was conducted in Kwale and Malindi 
Districts, Coast Province, which are both endemic of LF 
caused by Wuchereria bancrofti. Kwale District, 40 km 
south of Mombasa the second largest city in Kenya has 
an area of 8360km2 with a projected population of 
649,931 persons [5] and lies at an altitude of between 60 
and 135 meters above sea level.  Malindi District is 
located 120 kilometers northeast of Mombasa, and lies 
between latitudes 2.2º and 4º south and between 
longitudes 39º and 41º east. It covers a geographical 
area of 7, 605 square kilometers with a total population 
of 384,643 [5].  The prevalence of infection in Kwale is 
between 10-25 % [6; 7; 8; 9; 10]. The villages along 
River Sabaki in Malindi District have a prevalence of 
7.1% [11].  
 
Study design and data 
The study design was retrospective cross-sectional. In 
each districts, two locations were selected: one with 
high and the other with low treatment compliance. In 
Kwale, Tsimba location represented high and Gadini, 
low and in Malindi, Goshi represented high and 
Gongoni, low compliance. Using systematic sampling 
technique, a total of nine villages were selected from the 
four locations and then a total of 965 household heads 
or adult representatives randomly selected.  Interviewer-
based questionnaires were administered to the 
household heads or adult representatives for quantitative 
African Journal of Health Sciences, Volume 20, Number 1-2 January-March 2012 
 
44 
data. The details of the number of households covered are shown in Table 1. 
 
Table 1 Study population by district and MDA coverage in 2008  
 





Kwale Gandini Takawa 56 Low 
 Gandini Dzivani 84 Low 
 Gandini Tsunza 140 Low 
 Tsimba Patanani 100 High 
 Tsimba Mbengani 101 High 
Malindi Gongoni Zhogato 140 Low 
 Gongoni Midodoni 142 Low 
 Goshi Kavunyalalo 102 High 
 Goshi Magongoloni 100 High 
 
For the qualitative data, in-depth interviews were 
conducted with eighty LF patients with clinical signs 
and eighty opinion leaders all purposively selected to 
identify their opinion of MDA. To elicit more 
information on perceptions of MDA, sixteen focus 
group discussions (FGDs) were carried out with adult 
and youth male and female single-sex groups and 
moderated by the lead author assisted by trained field 
assistants using Kigiriama and Kiduruma, the local 
languages. Semi- structured interviews were 
administered to the fifteen community drug distributors 
who served the study villages in 2008 MDA, to the five 
health workers of the health facilities serving the 
selected villages and to the four District LF coordinators.  
The study received ethical clearance and approval from 
Kenya Medical Research Institute (KEMRI)/National 
Ethical Review Board (Protocol Number 1077) and 
World Health Organization, Ethical Review Committee 
(Tropical Diseases Research ID No. A61106). Informed 
consent was sought from the study participants. The 
hard copies of the raw data were stored in secure 
cabinets and the soft copies in computers with 
passwords with authorized access by the lead author for 
quality control.  
The responses to open-ended questions were coded 
before entry. Equivalent responses were pooled and 
arranged in different categories. The quantitative data 
were analyzed using SPSS version 16.  Categorical 
variables were summarized with frequencies and 
proportions and comparisons done using 2 test. The 
statistical significance was set at P  0.05. The 
qualitative data were analyzed manually according to 
the core themes of the study. The data were examined 
separately for clusters that recorded high and low 
coverage and compliance. 
The dependent variable, compliance with treatment, was 
assessed through verbal interviews with eligible 
household heads or adult representative. The 
independent variables were knowledge about MDA for 
LF, sources and content of MDA information, frequency 
of receiving the information and opinion towards the 
source of the information.    
 
Background Characteristics of the Respondents 
A total of 965 household heads or adult representatives 
with a mean age of 39.5 years (SD= 15.6) participated 
in the study. Most (62.6%) respondents were female, 
(80.4%) were in marital unions, 9.4%, single or 
divorced and 10.3%, widowed. Two-fifths (40.5%) were 
Christians, 35.8%-Muslims and 23.7% were non- 
practicing. Nearly one-half (45.8%) had never attended 
school while 30.7% attended but did not complete 
primary level. Most (62.5%) were peasant farmers, 
21.3% were casual laborers, fishermen or business 
owners. The remaining (16.1%) were either salaried 
workers or housewives. 
About one-quarter (24.6%) of the opinion leaders, 
interviewed were local leaders, 23.2%, Christian 
religious leaders and another 23.2%, social group 
leaders. Islamic leaders and traditional herbalist 
accounted for 5.8 % and 4.3 % respectively. Teachers 
and policemen represented 18.9% of this group. 
Nearly two-thirds (64%) of the LF patients had 
hydrocele, 35%, lymphoedema and only 1% had both 
manifestations. The mean age of the patients was 52.4 
years; (SD=16.7) the youngest was 22 and the oldest 98 
years old. Slightly more than two-thirds (67.5%) were 
male, one-half was from high and one-half from low 
compliance areas.  
 




Knowledge about Mass Drug Administration for 
Lymphatic Filariasis 
Knowledge about MDA for LF was not significantly 
associated with compliance (P>0.05). Seventy three 
percent of the respondents in low and 78% in high 
compliance villages reported that they knew about mass 
treatment for lymphatic filariasis elimination in their 
community. 
 
Source of MDA information 
The source of MDA information was associated with 
compliance (P< 0.001). Nearly one half (48.5%) of the 
respondents in the high compared to 39.9% in the low 
compliance villages received the information from the 
CDD. Less than one fifth (17.7%) of the respondents in 
high and 12.8% in low compliance villages received the 
information from village elder or the chief (Table 2). 
Table 2 Source of MDA information 
How did you learn about MDA? Low compliance % High compliance % 
CDD 39.9 48.5 
Hospital 3.9 0.5 
Radio/posters 4.8 2.7 
Village elder/chief 12.8 17.7 
Community members 5.5 2.7 
School 1.2 0.2 
Cannot remember 3.7 3.5 
Rumors 2.0 2.5 
N/A (did not know about MDA) 27 21.3 
Content of MDA information 
The content of information received about MDA was 
significantly associated with compliance, P< 0.001. 
Seventy-one percent of the respondents in high 
compared to 61% in the low compliance group received 
the correct information that the drugs were given to treat 
and control LF (Table 3).  
 
Table 3 Content of Information about LF Drugs 
What Information did you get about MDA drugs? Low 
compliance% 
High compliance % 
Drugs given to treat and control LF 61.3 71 
Cannot remember 5.2 3.2 
Do not know 6.6 2.2 
Drugs given for family planning and general health 0.9 1.5 
N/A Never got information 26 22 
 
Frequency of Receiving MDA information 
Frequency of receiving information on MDA was 
significantly associated with compliance, P< 0.001. 
Both high and low compliance village members 
received the information at least once, (65.5 % and 
50.3% respectively) while 10.5% in low compared to 
7.9% in high compliance villages did not know how 
many times they had received the information (Table 4). 
 
Table 4 Frequency of MDA Information 
How frequent was the MDA information? Low compliance % High compliance % 
Once 50.3 65.5 
Twice 9.6 4.0 
Thrice 2.5 0.5 
Several Times 0.9 0.9 
Do not know 10.5 7.9 
N/A Never got information 26.2 21.3 
Furthermore, in 4 FGDs in low and 2 in high 
compliance villages, majority of the participants 
reported that the community members were given MDA 
information one to two days before the MDA day. A 
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large majority of participants in 2 FGDs in low 
compliance villages reported that it took a very short 
period between the time they got the information and 
the time that the drugs were distributed.  
On the other hand, a great majority of participants of 7 
FGDs, 6 from high and one from a low compliance 
village said that they were given the MDA information 
3 days before MDA day. Moreover, most participants of 
3 FGDs, all from high compliant villages reported that 
they got the information 4 to 7 days before the MDA.  
In all FGDs, a great majority of the members 
emphasized that the communities needed to be given 
adequate sensitization and education about the LF 
programme. A male youth respondent in one FGD in a 
low compliance area said:  
“But the problem is that people were not educated on 
the drugs and the CDDs just came and gave out the 
drugs, they did not explain the negative and positive 
effect that is why many people did not swallow the 
drugs”.  
  
Three CDDs from low and one from high compliance 
villages further reported that their communities had not 
been informed about MDA. Moreover, 3 CDDs from 
high and 2 from low compliance villages reported that 
they informed their community members about the 
campaign during the actual drug distribution time. All 
the CDDs felt that there was inadequacy in source, 
content and frequency of MDA information and that 
combined effort by health workers, local administration 
through meetings, CDDs and mass media through 
posters and radio announcement needed to be used in 
order to raise the compliance levels.  
 
Only one health worker from a high compliance village 
reported having educated the community members on 
mass drug distribution by explaining the benefits of 
taking the LF drugs and the expected side effects while 
2 health workers from high and one from a low 
compliance village reported that they used the villages 
elders, CHWs and CDDs to educate the community 
members about the drugs. One health worker from a low 
compliance village reported that he could not educate 
his community as he was a new staff in the area and 
having come from a non-LF endemic area did not know 
much about the programme. Moreover, only one District 
LF coordinator mentioned community sensitization and 
health education as one of the recent steps taken to 
control LF in the area. 
 
Opinion towards source of MDA information 
Individual opinion towards source of MDA information 
was associated with compliance (P< 0.001). Forty six 
percent of the respondents in high compared to 42.6% in 
low compliance villages considered the source as good 
(Table 5).  
 
Table 5 View towards Source of MDA Information 
Opinion Low Compliance% High Compliance% 
Good 42.6 45.9 
Poor 5.1 12.4 
No Idea 15.0 8.0 
Needs to be more factual 11.1 12.4 





A female respondent in an FGD in a low compliance 
area further said: 
 
 “ I would like them to do like those who advertise using 
microphones or loud speakers in a car going house to 
house or different areas in the village explaining when 
the drugs will be given out, what they are for and who is 
required to take them. Also the village chairman should 
encourage his village people and many will get the 






The present study revealed that majority of the 
community members in both high and low compliance 
areas received information about the MDA campaign in 
their villages. However, it is apparent that several 
factors: access to MDA information, source of 
information, correctness of content of information on 
MDA, frequency of receiving the information and 
opinion towards sources varied between the two groups 
and influenced compliance with MDA uptake. 
In the current study, access to MDA information which 
seemed to have been better in high compared to low 
compliance areas influenced compliance with treatment. 
This finding is in tandem with the results of Wanji et al., 
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[12] which indicated that due to the social awareness 
campaign the population was well informed on the 
process and the role to play in the process which 
contributed much to the success of the programme and 
each partner in the community-directed treatment with 
ivermectin (CDTI) process adequately played his or her 
role.  World Health Organization [13], emphasizes that 
community involvement in health not only helps to 
break the bond of dependence that characterizes so 
much health development work but also creates a 
general awareness among local people of the potential 
for their involvement in all forms of development.   
The study results also showed that the sources of MDA 
information also influenced compliance with treatment. 
The CDDs followed by the chief and/or village elder 
were the most common sources of MDA information in 
both low and high compliance groups, while the hospital, 
press and print media were more common sources of 
information in the low compared to the high compliance 
areas. The results revealed that the health professionals 
did not play a frontline role in disseminating 
information on MDA suggesting that the MDA 
information received by some of the community 
members may have been inadequate and/or incorrect as 
the two main sources (CDDs and chiefs and/or villages 
elders) are non- health professionals who should not be 
relied upon as the main sources of information. 
Amarillo et al., [14] mentioned the important role of the 
health workers as the community’s major source of 
information indicating that their active and sustained 
participation is vital in running a five- year MDA 
programme to eliminate LF. Haselow et al., [15] on 
programmatic and communication issues in relation to 
serious adverse events following ivermectin treatment in 
areas co-endemic for onchocerciasis and loiasis 
mentioned that the community sensitization activities 
have typically been carried out by nurses and CDDs. 
Efforts of health workers may also need to be 
complemented with continuing if not intensified support 
from the local government unit. In Zanzibar, 
Mohammed et al., [16] where the programme has been 
successful, a combined message from an advisory board, 
ministries, national institutions, non-governmental 
organizations, (NGOs), religious organizations and 
political leaders were used to disseminate the 
information to the population.  
Although the compliance levels were different, the 
results of the current study show that majority of the 
community members in both high and low compliance 
groups knew about MDA. Similarly in Haiti, only about 
9% of the persons interviewed claimed to be unaware of 
mass drug administration [17]. In India however, 
Aswathy et al., [18] on perceptions and practices of 
MDA against filariasis in a rural community showed 
that a large proportion of the people did not know the 
term ‘mass drug administration’ although they lived in 
an area that had experienced three rounds of MDA in 
their lifetime. In the current study, other than having the 
correct information that the drugs were given to treat 
and prevent LF, some members could not remember or 
did not know why the drugs were given while some 
were misinformed and thought that the drugs were given 
for family planning and general good health. This 
suggests a need for adequate awareness creation and 
involvement of the target audience in deciding on the 
materials and methods to be used.  The findings of the 
current study are similar to those of Yirga et al., [19] 
where health education activities were very weak and 
could have otherwise provided epidemiological 
information that could have probably raised perceived 
risk of individuals to the disease. Furthermore, 
predominant reasons given for non-compliance were; 
thinking that the drugs were for only those with clinical 
manifestations and a lack of perceived need for the 
treatment [19].  
Health education could also raise awareness of the social, 
economic and environmental determinants of health, and 
be directed towards the promotion of individual and 
collective actions, which may lead to modification of 
these determinants. In the Philippines, Amarillo et al., 
[14] showed that nearly all those sampled did not know 
that a person with LF could be asymptomatic and the 
majority was only aware of the manifestations of the 
disease, which appear in its later stages. This lack of 
knowledge may have influenced their health-seeking 
behaviour such as waiting at home to receive the drugs 
and their perception of being infected, especially when 
they did not have symptoms and were not feeling unwell. 
Nutbeam, [20] expresses that in terms of ‘content’, 
efforts to improve people's knowledge, understanding 
and capacity to act, should not only be directed at 
changing personal lifestyle or the way in which people 
use the health services.  
The current study showed that majority of the 
community members from the low compliance areas 
had never heard of MDA and one-half got the 
information only once before the MDA. The findings 
therefore suggest that the low compliance community 
members may have had limited and infrequent exposure 
to health education materials. Rao and Sharma, [21] 
indicated that it is plausible that more frequent contact 
with the population before treatment could improve 
compliance especially if the contact involved health 
education. Mathieu et al., [22] however found that non-
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compliant persons were not less exposed to health 
education materials but did not retain or accept the 
messages. 
As more of the community members from the low 
compliance areas had never heard about MDA they 
therefore could not give their opinion towards the 
source of information or had no idea on what to 
comment about their views. This implies that the 
sources of MDA information in the low compliance 
areas were infrequent or rare and hence the low levels of 
compliance. Nutbeam, [21] in a report on health literacy 
as a public health goal, mentioned that interventions 
which have relied primarily on communication and 
education have mostly failed to achieve substantial and 
sustainable results in terms of behaviour change, and 
have made little impact in terms of closing the gap in 
health status between different social and economic 
groups in society. 
 
Conclusions 
This study advocates for improvement in making MDA 
information accessible to all targeted community 
members and for ensuring that health personnel 
participate adequately in information dissemination so 
as to build confidence among the target community 
members. Increasing the frequency of number of times 
of MDA information dissemination will help ensure that 
all members are aware of the programme. For higher 
compliance levels, different channels of information 
dissemination should be used in all communities. 
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